BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Careers Beyond Academia - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Careers Beyond Academia
X-ORIGINAL-URL:https://gradcareers.cornell.edu
X-WR-CALDESC:Events for Careers Beyond Academia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250923T190000
DTEND;TZID=America/New_York:20250923T200000
DTSTAMP:20260403T214824
CREATED:20250905T212127Z
LAST-MODIFIED:20250911T194535Z
UID:10002707-1758654000-1758657600@gradcareers.cornell.edu
SUMMARY:info session: BD Technology Leadership Development Program
DESCRIPTION:Considering transitioning to the medtech industry? Get insider tips to boost your chances. BD’s Technology Leadership Development Program (TLDP) provides PhD grads with three 1.5-2 year rotations tailored to their interests in medical device development. As a TLDP associate\, you shape a personalized career path targeting your skills and interests\, while gaining broad exposure to the business. The program is open to PhD graduates in STEM with between 0-3 years of post-grad experience. You are welcome to apply leading up to your defense\, or as a postdoc within three years of graduation. \nApply by Tuesday\, September 30th at BD Technology Leadership Development Program (TLDP) \nTo learn more about the program and help guide your application\, register to attend one of our information sessions below: \nSeptember 11\, 2025 2:00pm – 3:00pm EST\nSeptember 17\, 2025 5:00pm – 6:00pm EST\nSeptember 23\, 2025 7:00pm – 8:00pm EST \nUnfortunately no visa sponsorship is available for this program\, but you are encouraged to apply for scientist/sr. scientist and engineer positions within BD. \nConnect with previous TDLP Cornellians:\nTibra Wheeler PhD’21 Biomedical Engineering\nKarla García-Martínez\, PhD’23 Immunology & Infectious Diseases\nRob Swanda PhD’21 Biochemistry\nCourtney Jackson PhD Microbiology \nWatch a short video summarizing the value of the TDLP from the perspective of past participants.
URL:https://gradcareers.cornell.edu/event/info-session-bd-technology-leadership-development-program/2025-09-23/
LOCATION:Online
CATEGORIES:Careers Beyond Academia
ATTACH;FMTTYPE=image/png:https://gradcareers.cornell.edu/wp-content/uploads/2022/01/bd-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250925T120000
DTEND;TZID=America/New_York:20250925T133000
DTSTAMP:20260403T214824
CREATED:20250905T162920Z
LAST-MODIFIED:20250905T212807Z
UID:10002704-1758801600-1758807000@gradcareers.cornell.edu
SUMMARY:Career Paths in Pre-Clinical Development
DESCRIPTION:Join scientists involved in preclinical development at Merck for a session where you will learn how a variety of disciplines are involved in bringing pharmaceuticals from discovery\, through development\, and to the clinic. You’ll hear from Merck scientists about their career paths and how you might leverage your training for exciting positions in pharmaceutical development. The session will include a Q&A session with Merck scientists\, and you’ll learn how to stay up to date about openings in Preclinical Development. Broadly\, this session will be of interest to trainees in a variety of fields of biological sciences\, chemistry\, and/or data science who would like to learn more about careers in the pharmaceutical industry. \nHosted by Merck in collaboration with Cornell\, Rutgers\, Brown\, and the University of Chicago. \nRegistration\nRegister for this online event by joining the Merck community. The meeting will be used on Microsoft’s Teams platform\, so be sure to download access beforehand. It is optional to upload your resume. \nAbout the panelists\nRupesh P. Amin\, PhD\,is an Executive Director in Nonclinical Drug Safety at Merck. He has 23 years of experience from both small and large pharmaceutical companies across various aspects of toxicology\, investigative toxicology\, nonclinical drug discovery and development across multiple therapeutic areas and modalities. Rup has successfully supported the advancement of Cardiometabolic\, Anti-inflammatory\, Oncology and RNA therapeutic drugs. In his current role as Head of Program Development\, Dr. Amin provides nonclinical drug safety scientific\, operational\, and strategic oversight for Merck’s development programs across all therapeutic areas and modalities. His team supports programs entering Phase 1 through registration and post-marketing\, ensuring nonclinical drug safety aspects support the clinical program. Additionally\, Dr. Amin’s team provides oversight of Occupational Toxicology aspects of Merck’s portfolio. This involves critically assessing the potential hazardous effects of chemicals and drugs to guide the implementation of measures to protect employee health and safety. Before joining industry in 2002\, Dr. Amin completed a Ph.D. in Toxicology at the Joint Graduate Program in Toxicology at Rutgers University/Robert Wood Johnson Medical School. He further pursued a post-doctoral fellowship applying toxicogenomic approaches to elucidate molecular mechanisms in drug-induced renal toxicity and studied cell cycle defects at the National Institute of Environmental Health Sciences. Rup enjoys travelling\, hiking and exploring diverse cuisines with his wife and 3 kids.  \nMelissa Dsouza\, PhD\, is a Director in Digital Operations and Innovation within Nonclinical Drug Safety at Merck Research Labs. She specializes in applying data science and machine learning to drug safety assessment. She earned her Ph.D. in Microbiology from the University of Auckland in New Zealand in 2015\, where she also completed her B.Tech in Biotechnology with First-Class Honors. \nWith over 10 years of experience spanning academia and the microbiome industry\, Melissa brings her expertise in bioinformatics\, microbial ecology\, and statistical modeling to her role at Merck. Before joining Merck in 2021\, she held leadership positions at microbiome therapeutics companies\, including Vedanta Biosciences and Commense Inc.\, where she developed novel analytical methods for microbial drug characterization and led clinical bioinformatics efforts supporting Phase 1/2 trials for live biotherapeutic products. At Merck\, she provides technical leadership for data science initiatives\, builds predictive models using diverse datasets\, and collaborates across research teams to develop AI solutions for drug safety assessment. She is passionate about leveraging historical datasets and advanced analytics to generate meaningful insights that advance drug development. \nKara Pearson\, PhD’00 Chemistry\, is the Director of Analytical & Biochemical Toxicology in the Investigative Toxicology group within Nonclinical Drug Safety at Merck where she manages a group of analytical chemists\, biochemists and cell biologists who perform investigative studies to understand mechanisms of toxicity and support development of alternative models for safety testing. During her 24 years in Nonclinical Drug Safety\, Kara has worked at the bench\, lead interdepartmental investigations into mechanisms of toxicity\, and served as a departmental representative to program Discovery and Development Teams. The challenges of drug development are always evolving\, so interdisciplinary collaboration is key to our success and one of the most rewarding aspects of the job. Ensuring the safety of our new therapeutics is another.  Kara completed her PhD in bioorganic chemistry at Cornell University in 2000 and followed that with postdoctoral research in the NIH’s National Heart\, Lung and Blood Institute Lab of Biophysical Chemistry before joining the Merck team. \nKristen A. Roosa\, PhD’15 Biological and Biomedical Sciences is an Associate Principal Scientist in the Developmental and Reproductive Toxicology group\, part of the Nonclinical Drug Safety division\, at Merck. She conducts animal studies to assess potential risks of new pharmaceuticals to human fertility\, embryo-fetal and postnatal development and serves as a subject matter expert for teams developing strategies for nonclinical safety assessment programs. She completed her PhD in the Biological and Biomedical Sciences program at Cornell in 2015\, started her career in academia at a primarily undergraduate institution\, and then made the move to industry in 2021. \nKetal Shah\, BA\, is an Associate Principal Scientist at Merck with over two decades of experience in the pharmaceutical\, biotechnology\, and CRO sectors. She specializes in biochemistry\, molecular biology\, and immuno-analytical techniques\, with a strong track record of leading outsourcing collaborations and advancing complex research programs. Throughout her career\, Ketal has held scientific roles at Roche\, Elusys Therapeutics\, Ortho Clinical Diagnostics\, and Tandem Labs before joining Merck in 2014. She is recognized for her critical thinking\, problem-solving skills\, and ability to build effective cross-functional partnerships in fast-paced environments. Ketal holds a B.A. in Biochemistry from Rutgers University. \nEvent Date\, Time and Location\nOnline: Thursday\, September 25\, 2025 \, 12:00 PM – 1:30 PM (EDT) \nThe event is a follow-up to a successful Cornell University campus visit in 2023\, broadening it this year to include additional university collaborators and partners.
URL:https://gradcareers.cornell.edu/event/career-paths-in-pre-clinical-development/
LOCATION:Online
CATEGORIES:Careers Beyond Academia
ATTACH;FMTTYPE=image/png:https://gradcareers.cornell.edu/wp-content/uploads/2025/09/Screenshot-2025-09-05-at-17.27.07.png
END:VEVENT
END:VCALENDAR